Zelira Therapeutics Ltd (ZLD)

Sydney
0.039
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.038/0.039
  • Day's Range:
    0.038 - 0.039

ZLD Overview

Prev. Close
0.037
Day's Range
0.038-0.039
Revenue
2.09M
Open
0.039
52 wk Range
0.035-0.14
EPS
-0.01
Volume
0
Market Cap
44.04M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,071,109
P/E Ratio
-
Beta
2.34
1-Year Change
-58.51%
Shares Outstanding
1,190,322,966
Next Earnings Date
-
What is your sentiment on Zelira Therapeutics Ltd?
or
Market is currently closed. Voting is open during market hours.

Zelira Therapeutics Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyNeutralStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell

Zelira Therapeutics Ltd Company Profile

Zelira Therapeutics Ltd Company Profile

Employees
8
Market
Australia

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based medicines for the treatment of various medical conditions in Australia. The company is also involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. Zelira Therapeutics has strategic partnerships with Curtin University; the Telethon Kids Institute; the University of Western Australia; St. Vincent’s Hospital; the Children’s Hospital of Philadelphia (CHOP) on opioid reduction study; HAPA Pharm BV; and Ethicann. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was founded in 2003 and is headquartered in Perth, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.